Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
The genetics of anthracycline-induced cardiotoxicity in cancer patients
INTRODUCTION: Breast cancer makes up 25% of all cancers diagnosed worldwide. Despite an increasing yearly incidence, there has been a significant decrease in mortality owing to early diagnosis and advances in treatment. Anthracycline-based chemotherapy is a relatively low cost yet highly effective a...
Saved in:
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Thesis |
| Language: | English |
| Published: |
Division of Human Genetics
2018
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
Similar Items: The genetics of anthracycline-induced cardiotoxicity in cancer patients
- Anthracycline-induced cardiotoxicity : the role of proteolytic pathways
- The prevalence of anthracycline-induced cardiotoxicity post-cancer treatment in a South African paediatric oncology unit
- Atomistic Assessment of Drug-Phospholipid Interactions Consequent to Cancer Treatment: A Study of Anthracycline Cardiotoxicity
- The (un)SAFE and RISK(y) sides of doxorubicin-induced cardiotoxicity
- The molecular genetic and epidemiological investigation of colorectal cancer in South Africa
- Study of genetic modifiers of fetal hemoglobin and mechanisms of hydroxyurea-induced γ-globin expression in sickle cell disease